Metabolic [ftcn]
Inflammatory [ftcn]
haemostatic [ortf]
effects [qlco]
Low dose [qnco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Women [popg]
Safeties [hcpp]
respect [socb]
vascular [bpoc]
Risk [qlco]
Background [cnce]
Conventional [qlco]
Hormone replacement therapy [topp]
Containing [ftcn]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
cee [orch]
medroxyprogesterone acetate [horm, phsu, strd]
Increase [ftcn]
Triglyceride [bacs, lipd]
C-reactive protein [aapp, imft]
Coagulation Factor VII [aapp, bacs, phsu]
Concentrations [menp]
Increased [qnco]
coronary heart disease [dsyn]
Stroke risk [inpr]
Objective [inpr]
Assess [acty]
metabolic effects [phsf]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Containing [ftcn]
mg% [qnco]
Estradiol [horm, phsu, strd]
mg% [qnco]
Norethisterone [horm, phsu, strd]
MATCHING [resa]
placebo [topp]
Design [acty]
DOUBLE BLIND [resa]
randomized controlled trial [inpr, resa]
placebo [topp]
Patients [podg]
Women [popg]
measurements [ftcn]
Classical [qlco]
Novel [tmco]
risk factors [qnco]
Vascular disease [dsyn]
Result [ftcn]
Triglyceride [bacs, lipd]
Concentration [menp]
Not [ftcn]
Altered [ftcn]
P NOS [aapp, imft]
Change [ftcn]
Active [ftcn]
Arm [blor]
Relative [famg]
placebo [topp]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Concentration [menp]
P NOS [aapp, imft]
Concentration [menp]
Mean [qnco]
pg/mL [qnco]
IU/dL [qnco]
P NOS [aapp, imft]
Factor VII [aapp, bacs, phsu]
IU/dL [qnco]
IU/L [qnco]
P NOS [aapp, imft]
Tissue Plasminogen Activator Antigen [imft]
P NOS [aapp, imft]
Concentrations [menp]
Fall [fndg]
C-reactive protein [aapp, imft]
Not [ftcn]
Altered [ftcn]
P NOS [aapp, imft]
Fasting [fndg]
Glucose [bacs, carb, phsu]
P NOS [aapp, imft]
effects [qlco]
Factor IX [aapp, bacs, phsu]
APC Resistance [dsyn]
Conclusions [idcn]
Hormone replacement therapy [topp]
Containing [ftcn]
mg% [qnco]
Estradiol [horm, phsu, strd]
mg% [qnco]
Norethisterone [horm, phsu, strd]
metabolic effects [phsf]
Elevated [qlco]
coronary heart disease [dsyn]
Stroke risk [inpr]
Induced [ftcn]
Conventional [qlco]
High dose [qnco]
Hormone replacement therapy [topp]
This [euka]
Type [qlco]
Preparation [ftcn]
More [ftcn]
Conventional [qlco]
Hormone replacement therapy [topp]
Women [popg]
Elevated [qlco]
Coronary heart disease risk [inpr]
With [qlco]
Large [qnco]
randomized controlled trials [inpr, resa]
Low dose [qnco]
Preparation [ftcn]
powered [hcpp]
CARDIOVASCULAR [bdsy]
End Point [qlco]
Now [tmco]
Needed [qlco]
